Company Filing History:
1 out of 1 
1 out of 3 Years Active: 2024
Title: Hironobu Ihn: Innovator in Fibrosis Treatment
Introduction
Hironobu Ihn is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases characterized by fibrosis. His innovative approach has led to the development of a unique drug formulation aimed at addressing this critical health issue.
Latest Patents
Hironobu Ihn holds a patent for a fibrosis drug. The present invention provides a pharmaceutical composition for preventing and/or treating a disease characterized by fibrosis of a cell or a tissue. This composition comprises a compound represented by formula 1 or a salt thereof, along with a pharmaceutically acceptable carrier. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Hironobu Ihn has worked with various companies, including Science Farm Ltd. and Link Genomics, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research in fibrosis treatment.
Collaborations
Hironobu Ihn has collaborated with notable colleagues such as Lin Kurahara and Masami Otsuka. These partnerships have contributed to the development of innovative solutions in the pharmaceutical industry.
Conclusion
Hironobu Ihn's work in developing a fibrosis drug showcases his dedication to medical innovation. His contributions to the field are significant and reflect his expertise as an inventor. His ongoing efforts continue to inspire advancements in the treatment of fibrosis-related diseases.